Our execution was solid this quarter, with continued top-line growth in international markets, meaningful gross-margin accretion from productivity, and renewed investment behind key brands.
— Rod Little
03Detailed Report
EPC
Company EPC
Period
Q2 2025
CurrencyUSD
Report TypeQuarterly Earnings
GeneratedJun 28, 2026
Swipe to view all report sections
Executive Summary
Edgewell Personal Care (EPC) reported QQ2 2025 results that reflected a modest YoY revenue decline yet solid gross margin progression and meaningful productivity savings, underpinning a constructive path on the transformation of the business. Organic net sales declined 1.5% for the quarter, driven by a slower-than-anticipated U.S. Fem Care recovery and weather-related softness in Sun Care, while international markets continued to demonstrate resilient growth with 3% organic growth. Total revenue stood at $580.7 million for the quarter. The company delivered gross margin expansion of 100 basis points on an adjusted basis (about 110 bps in constant currency), supported by 380 basis points of productivity savings, and EBITDA of $99.3 million. Net income was $29 million and GAAP EPS was $0.60, with adjusted EPS of $0.87 (vs. $0.88 prior year) impacted by a higher tax rate and currency dynamics.
Management underscored the ongoing transformation agenda: replatforming international operations, accelerating innovation with brand renovations (e.g., Billie, Bulldog, Protista, Cremo), and a broad efficiency program that has delivered more than 200 bps of COGS savings annually. North America remains the biggest near-term growth opportunity, with leadership changes and an intensified commercial program designed to restore momentum in Sun Care and Shave. The company signaled a more cautious but deliberate 2H outlook, acknowledging macro volatility and tariff-related costs. The updated full-year guidance contemplates flat-to-low-single-digit organic net sales growth, gross margin accretion of roughly 70 bps in full-year terms (net of incremental tariffs), and adjusted EPS in the $2.85–$3.05 range with free cash flow of $130–$140 million. Management emphasized pursuing productivity, price/mix discipline, and incremental brand investments to support the North America rebound and international strength. Investors should monitor tariff developments, the pace of North America execution, and the effectiveness of the Hawaii Tropic/Billie campaigns as pivotal drivers of the 2H trajectory.
Key Performance Indicators
Revenue
Decreasing
580.70M
QoQ: 21.38% | YoY: -3.12%
Gross Profit
Decreasing
256.20M
44.12% margin
QoQ: 33.72% | YoY: -0.74%
Operating Income
Decreasing
58.90M
QoQ: 190.15% | YoY: -15.98%
Net Income
Decreasing
29.00M
QoQ: 1 480.95% | YoY: -19.44%
EPS
Decreasing
0.60
QoQ: 1 492.11% | YoY: -16.67%
Revenue Trend
Margin Analysis
Financial Highlights
- Revenue: $580.7 million in Q2 2025 (YoY -3.12%, QoQ +21.38%)
- Gross Profit: $256.2 million; Gross Margin (GAAP) ≈ 44.1%; Adjusted Gross Margin +100 bps YoY (≈110 bps in constant currency)
- Operating Income: $58.9 million; Operating Margin ≈ 10.14% (YoY margin declined; currency headwinds offset margin gains)
- EBITDA: $83.3 million; EBITDA Margin ≈ 14.34%
- Net Income: $29.0 million; Net Margin ≈ 4.99%; EPS (GAAP) $0.60; Adjusted EPS $0.87 (vs. $0.88 prior year; tax headwind ~ $0.06)
- Cash Flow: Operating cash flow $45.1 million; Free cash flow $28.0 million; Net cash from operating activities $45.1 million; Net change in cash -$5.4 million; Cash and cash equivalents $170.1 million; Undrawn revolver capacity $229 million; Net debt $1.3069 billion; Leverage 3.8x
- Balance Sheet: Total assets $3.7728 billion; Total liabilities $2.2589 billion; Total stockholders’ equity $1.5139 billion; Debt ratio ~0.391; Debt/Capitalization ~0.494; Current ratio ~1.89; Days Inventory Outstanding ~142 days; DSO ~36 days; DPO ~60 days
- Guidance (full year): Organic net sales flat to +1%; Q3 net sales +1%; H2 net sales +2%; Adjusted EPS $2.85–$3.05; Adjusted EBITDA $329–$341 million; Free cash flow $130–$140 million; Tariff headwinds ~$3–4 million in COGS for the year; Currency headwinds modest; Incremental A&P investments in 3Q (~$7 million gross) impacting gross margin in the near term.
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
580.70M
-3.12%
21.38%
Gross Profit
256.20M
-0.74%
33.72%
Operating Income
58.90M
-15.98%
190.15%
Net Income
29.00M
-19.44%
1 480.95%
EPS
0.60
-16.67%
1 492.11%
Key Financial Ratios
Gross Profit Margin
Good
44.10%
Gross profit margin is healthy and competitive within industry standards
Operating Profit Margin
Fair
10.10%
Operating margin is moderate, room for improvement in cost management
Net Profit Margin
Fair
4.99%
Net profit margin is moderate, room for improvement in cost management
Return on Assets
Weak
0.77%
Return on assets suggests inefficient capital allocation
Return on Equity
Weak
1.92%
Return on equity suggests inefficient capital allocation
Current Ratio
Healthy
1.89
Current ratio shows adequate liquidity to meet short-term obligations
Edgewell Personal Care Company (EPC) QQ1 2025 Results – International Growth Momentum, FX Headwinds Pressuring Profitability, Strategic Transformati...
Edgewell Personal Care Company (EPC) QQ2 2024 Earnings Analysis: Margin Expansion, Broad Portfolio Momentum and International Growth Amid North Americ...